129 related articles for article (PubMed ID: 19230382)
1. Inhibition of DNA topoisomerase II with etoposide induces association of DNA topoisomerase II alpha, DNA topoisomerase II beta, and nucleolin with BCR 2 of the ETO gene.
Rubtsov MA; Razin SV; Iarovaia OV
Dokl Biochem Biophys; 2008; 423():334-6. PubMed ID: 19230382
[No Abstract] [Full Text] [Related]
2. The role of topoisomerase II beta on breakage and proximity of RUNX1 to partner alleles RUNX1T1 and EVI1.
Smith KA; Cowell IG; Zhang Y; Sondka Z; Austin CA
Genes Chromosomes Cancer; 2014 Feb; 53(2):117-28. PubMed ID: 24327541
[TBL] [Abstract][Full Text] [Related]
3. Repositioning of ETO gene in cells treated with VP-16, an inhibitor of DNA-topoisomerase II.
Rubtsov MA; Terekhov SM; Razin SV; Iarovaia OV
J Cell Biochem; 2008 May; 104(2):692-9. PubMed ID: 18183572
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional regulation by the t(8;21) fusion protein, AML-1/ETO.
Hiebert SW; Downing JR; Lenny N; Meyers S
Curr Top Microbiol Immunol; 1996; 211():253-8. PubMed ID: 8585956
[No Abstract] [Full Text] [Related]
5. NHR4 domain mutations of ETO are probably very infrequent in AML1-ETO positive myeloid leukemia cells.
Hackanson B; Abdelkarim M; Jansen JH; Lübbert M
Leukemia; 2010 Apr; 24(4):860-1. PubMed ID: 20090777
[No Abstract] [Full Text] [Related]
6. [Topoisomerase II inhibitors etoposide and doxorubicin induced rearrangement and fusion of AML1 gene].
Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2003 Dec; 24(12):621-3. PubMed ID: 14761607
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase inhibitors induce the degradation of the t(8;21) fusion oncoprotein.
Yang G; Thompson MA; Brandt SJ; Hiebert SW
Oncogene; 2007 Jan; 26(1):91-101. PubMed ID: 16799637
[TBL] [Abstract][Full Text] [Related]
8. A new complex translocation t(8;11;21)(q22;q24;q22) in acute myeloid leukemia with RUNX1/RUNX1T1.
Yamamoto K; Yakushijin K; Funakoshi Y; Sanada Y; Kawamoto S; Matsuoka H; Minami H
J Clin Exp Hematop; 2014; 54(2):167-70. PubMed ID: 25318951
[No Abstract] [Full Text] [Related]
9. Wnt signaling induces transcription, spatial proximity, and translocation of fusion gene partners in human hematopoietic cells.
Ugarte GD; Vargas MF; Medina MA; León P; Necuñir D; Elorza AA; Gutiérrez SE; Moon RT; Loyola A; De Ferrari GV
Blood; 2015 Oct; 126(15):1785-9. PubMed ID: 26333776
[TBL] [Abstract][Full Text] [Related]
10. The AML1/ETO fusion protein activates transcription of BCL-2.
Klampfer L; Zhang J; Zelenetz AO; Uchida H; Nimer SD
Proc Natl Acad Sci U S A; 1996 Nov; 93(24):14059-64. PubMed ID: 8943060
[TBL] [Abstract][Full Text] [Related]
11. Junctions of the AML1/MTG8(ETO) fusion are constant in t(8;21) acute myeloid leukemia detected by reverse transcription polymerase chain reaction.
Kozu T; Miyoshi H; Shimizu K; Maseki N; Kaneko Y; Asou H; Kamada N; Ohki M
Blood; 1993 Aug; 82(4):1270-6. PubMed ID: 8353289
[TBL] [Abstract][Full Text] [Related]
12. Use of the polymerase chain reaction in the detection of AML1/ETO fusion transcript in t(8;21).
Kwong YL; Chan V; Wong KF; Chan TK
Cancer; 1995 Feb; 75(3):821-5. PubMed ID: 7828132
[TBL] [Abstract][Full Text] [Related]
13. The AML1 gene in the 8;21 and 3;21 translocations in chronic and acute myeloid leukemia.
Nucifora G; Rowley JD
Cold Spring Harb Symp Quant Biol; 1994; 59():595-605. PubMed ID: 7587119
[No Abstract] [Full Text] [Related]
14. Identification of two transcripts of AML1/ETO-fused gene in t(8;21) leukemic cells and expression of wild-type ETO gene in hematopoietic cells.
Era T; Asou N; Kunisada T; Yamasaki H; Asou H; Kamada N; Nishikawa S; Yamaguchi K; Takatsuki K
Genes Chromosomes Cancer; 1995 May; 13(1):25-33. PubMed ID: 7541640
[TBL] [Abstract][Full Text] [Related]
15. Transcriptional upregulation of p21/WAF/Cip1 in myeloid leukemic blasts expressing AML1-ETO.
Berg T; Fliegauf M; Burger J; Staege MS; Liu S; Martinez N; Heidenreich O; Burdach S; Haferlach T; Werner MH; Lübbert M
Haematologica; 2008 Nov; 93(11):1728-33. PubMed ID: 18790797
[TBL] [Abstract][Full Text] [Related]
16. ETO and AML1 phosphoproteins are expressed in CD34+ hematopoietic progenitors: implications for t(8;21) leukemogenesis and monitoring residual disease.
Erickson PF; Dessev G; Lasher RS; Philips G; Robinson M; Drabkin HA
Blood; 1996 Sep; 88(5):1813-23. PubMed ID: 8781439
[TBL] [Abstract][Full Text] [Related]
17. Synergistic up-regulation of the myeloid-specific promoter for the macrophage colony-stimulating factor receptor by AML1 and the t(8;21) fusion protein may contribute to leukemogenesis.
Rhoades KL; Hetherington CJ; Rowley JD; Hiebert SW; Nucifora G; Tenen DG; Zhang DE
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11895-900. PubMed ID: 8876234
[TBL] [Abstract][Full Text] [Related]
18. The AML1 and ETO genes in acute myeloid leukemia with a t(8;21).
Nucifora G; Rowley JD
Leuk Lymphoma; 1994 Aug; 14(5-6):353-62. PubMed ID: 7812194
[TBL] [Abstract][Full Text] [Related]
19. Translocation (8;21)(q22;q22) without rearrangement of RUNX1 and RUNX1T1 genes in a patient with refractory anemia with excess of blasts.
Aguilar A; Talavera M; Villalon C; Garcia-Sagredo JM; de Leon A; Sordo T; Cabello P; Gonzalez FA; Garcia-Galloway E; San Roman C; Ferro T
Cancer Genet Cytogenet; 2008 Jan; 180(1):85-6. PubMed ID: 18068542
[No Abstract] [Full Text] [Related]
20. Replication-dependent and transcription-dependent mechanisms of DNA double-strand break induction by the topoisomerase 2-targeting drug etoposide.
Tammaro M; Barr P; Ricci B; Yan H
PLoS One; 2013; 8(11):e79202. PubMed ID: 24244448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
